AI assistant
Sending…
Solana Co — Director's Dealing 2024
Jul 5, 2024
32724_dirs_2024-07-05_8449d61b-ca05-4a9c-9e3b-b26a2df8419d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2024-07-02
Reporting Person: MATHIESEN JEFFREY S (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-07-02 | Stock Option (Right to Buy) | $0.965 | A | 404000 | Acquired | 2034-07-01 | Class A Common Stock (404000) | Direct |
Footnotes
F1: Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 62.5% of the options vested immediately upon grant, and the remaining options vest in a series of ten (10) successive equal quarterly installments on the last day of each quarter starting on September 30, 2024, subject to the Reporting Person's continued service through each applicable vesting period.
More from Solana Co
Capital/Financing Update
2026
May 29
Share Issue/Capital Change
2026
May 29
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 22
Proxy Solicitation & Information Statement
2026
May 15
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Capital/Financing Update
2026
Apr 27
Capital/Financing Update
2026
Apr 27
Annual Report
2026
Apr 14